Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.71M Sell
6,889
-3,775
-35% -$3.19M 0.03% 374
2026
Q1
$7.87M Sell
10,664
-2,791
-21% -$2.03M 0.04% 319
2025
Q4
$8.23M Sell
13,455
-13,988
-51% -$9.06M 0.04% 295
2025
Q3
$17.8M Buy
27,443
+130
+0.5% +$78.9K 0.09% 193
2025
Q2
$14.6M Buy
27,313
+19,373
+244% +$8.55M 0.08% 201
2025
Q1
$2.93M Buy
7,940
+1,675
+27% +$724K 0.02% 435
2024
Q4
$2.84M Sell
6,265
-334
-5% -$158K 0.02% 449
2024
Q3
$2.84M Buy
6,599
+2,465
+60% +$930K 0.02% 447
2024
Q2
$1.51M Buy
+4,134
New +$1.53M 0.01% 530
2022
Q3
Sell
-5,734
Closed -$590K 880
2022
Q2
$590K Sell
5,734
-24,409
-81% -$2.61M ﹤0.01% 708
2022
Q1
$3.4M Sell
30,143
-18,909
-39% -$2.23M 0.02% 429
2021
Q4
$6.25M Buy
49,052
+8,930
+22% +$1.11M 0.04% 317
2021
Q3
$4.63M Buy
40,122
+14,884
+59% +$1.78M 0.03% 413
2021
Q2
$3.11M Buy
+25,238
New +$3.08M 0.02% 503

Other funds holding EME

Candriam SCA's EME Position: Q2 2026 in Review

Candriam SCA reduced its Emcor (EME) stake by 35% in Q2 2026, selling an estimated $3.19M and leaving 6,889 shares worth $5.71M. The position accounts for 0.03% of the portfolio, ranked #374.

Candriam SCA first reported a position in EME in Q2 2021 and has held it in 14 quarters since. The position peaked at $17.8M in Q3 2025. 1,240 funds tracked by Wall St. Rank hold EME as of Q2 2026.

  • Candriam SCA held 6,889 shares of Emcor worth $5.71M as of Q2 2026.
  • Candriam SCA sold 3,775 Emcor shares in Q2 2026, an estimated $3.19M.
  • Emcor made up 0.03% of Candriam SCA's portfolio in Q2 2026, its #374 holding.
  • Candriam SCA first reported a position in Emcor in Q2 2021 and has held it in 14 quarters since.
  • Candriam SCA's Emcor position peaked at $17.8M in Q3 2025.
  • 1,240 funds tracked by Wall St. Rank held Emcor as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.